The Medicinal Chemistry of Caffeine.
3',5'-Cyclic-AMP Phosphodiesterases
/ antagonists & inhibitors
Caffeine
/ chemistry
Chemistry, Pharmaceutical
Glycogen Phosphorylase
/ antagonists & inhibitors
Humans
Neurodegenerative Diseases
/ drug therapy
Neuroprotective Agents
/ chemistry
Pain
/ drug therapy
Purinergic P1 Receptor Antagonists
/ chemistry
Receptors, Purinergic P1
/ chemistry
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
10 06 2021
10 06 2021
Historique:
pubmed:
22
5
2021
medline:
22
6
2021
entrez:
21
5
2021
Statut:
ppublish
Résumé
The purine alkaloid caffeine is the most widely consumed psychostimulant drug in the world and has multiple beneficial pharmacological activities, for example, in neurodegenerative diseases. However, despite being an extensively studied bioactive natural product, the mechanistic understanding of caffeine's pharmacological effects is incomplete. While several molecular targets of caffeine such as adenosine receptors and phosphodiesterases have been known for decades and inspired numerous medicinal chemistry programs, new protein interactions of the xanthine are continuously discovered providing potentially improved pharmacological understanding and a molecular basis for future medicinal chemistry. In this Perspective, we gather knowledge on the confirmed protein interactions, structure activity relationship, and chemical biology of caffeine on well-known and upcoming targets. The diversity of caffeine's molecular activities on receptors and enzymes, many of which are abundant in the CNS, indicates a complex interplay of several mechanisms contributing to neuroprotective effects and highlights new targets as attractive subjects for drug discovery.
Identifiants
pubmed: 34019396
doi: 10.1021/acs.jmedchem.1c00261
doi:
Substances chimiques
Neuroprotective Agents
0
Purinergic P1 Receptor Antagonists
0
Receptors, Purinergic P1
0
Caffeine
3G6A5W338E
Glycogen Phosphorylase
EC 2.4.1.-
3',5'-Cyclic-AMP Phosphodiesterases
EC 3.1.4.17
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
7156-7178Subventions
Organisme : NIGMS NIH HHS
ID : P41 GM103311
Pays : United States